Oyster Point Pharma, Inc. Common Stock
OYST
OYST was delisted on the 30th of December, 2022.
1 hedge funds and large institutions have $11 invested in Oyster Point Pharma, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 52 closing their positions.
98% less funds holding
Funds holding: 53 → 1 (-52)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $189M → $11 (-$189M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 52
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$66.2M |
| 2 |
IFA
Invus Financial Advisors
New York
|
-$30.9M |
| 3 |
RI
RTW Investments
New York
|
-$25.7M |
| 4 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$11.6M |
| 5 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
-$7.32M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Wells Fargo
San Francisco,
California
| – | -$1.28K | -115 | Closed |
|
|
IA
52
IFP Advisors
Tampa,
Florida
| – | -$2K | -106 | Closed |
|
|
BAM
53
Belpointe Asset Management
Reno,
Nevada
| – | -$112 | -10 | Closed |
|
OYST Hedge Fund Activity: Q1 2023 in Review
1 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Oyster Point Pharma, Inc. Common Stock (OYST) for Q1 2023, worth a combined $11 — down 100% from $189M a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of OYST and 0 opened new positions — a net loss of 52 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was NEA Management Company, exiting entirely with an estimated $66.2M sold.
- 1 institutional investor held Oyster Point Pharma, Inc. Common Stock (OYST) as of Q1 2023, down from 53 in Q4 2022.
- Funds reported $11 of Oyster Point Pharma, Inc. Common Stock stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new Oyster Point Pharma, Inc. Common Stock positions in Q1 2023 and 52 closed out, a net change of -52 holders.
- The largest Oyster Point Pharma, Inc. Common Stock seller in Q1 2023 was NEA Management Company, an estimated $66.2M sold.
Based on aggregated 13F filings for Q1 2023.